SEC
|
Kim Bobae
|
VP Reg. Affairs & Quality
|
|
-9.5K
|
$10.00
|
-$94.55K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+8.2K
|
$4.00
|
+$32.76K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+609K
|
$4.00
|
+$2.44M
|
|
SEC
|
KLINSKY STEVEN B
|
N/A
|
|
-400K
|
$5.48
|
-$2.19M
|
|
SEC
|
FARES Wassim
|
Chief Medical Officer
|
|
+4K
|
$10.18
|
+$40.72K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+7.6K
|
$12.77
|
+$96.87K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+1.2M
|
$13.00
|
+$15.00M
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+8.4K
|
$0.38
|
+$3.21K
|
|
SEC
|
Dekker Martin
|
VP of Engineering & Manuf
|
|
-27K
|
$0.34
|
-$9.23K
|
|
SEC
|
Fernandes Peter
|
Chief Regulatory & Safety Offr
|
|
-40K
|
$0.34
|
-$13.70K
|
|
SEC
|
Korner Assaf
|
CFO
|
|
-33K
|
$0.34
|
-$11.22K
|
|
SEC
|
Shah Parag Suresh
|
VP of Business Operations
|
|
-26K
|
$0.34
|
-$8.84K
|
|
SEC
|
Tenenbaum Fabian
|
Chief Executive Officer
|
|
-77K
|
$0.34
|
-$26.12K
|
|
SEC
|
VHCP Management III, LLC
|
N/A
|
|
-1.1M
|
$0.48
|
-$525.05K
|
|
SEC
|
VHCP Management II, LLC
|
N/A
|
|
-1.1M
|
$0.48
|
-$525.05K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+50K
|
$0.64
|
+$32.00K
|
|
SEC
|
Edmonds Amy
|
VP Clinical Operations & Admin
|
|
-36K
|
$0.61
|
-$21.85K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+28K
|
$0.60
|
+$16.50K
|
|
SEC
|
Peacock Jonathan M
|
N/A
|
|
+20K
|
$0.61
|
+$12.20K
|
|
SEC
|
Tenenbaum Fabian
|
Chief Executive Officer
|
|
+5K
|
$0.60
|
+$3.00K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+43K
|
$0.61
|
+$26.40K
|
|
SEC
|
Amin Naseem
|
N/A
|
|
+571K
|
$0.70
|
+$400.00K
|
|
SEC
|
Peacock Jonathan M
|
N/A
|
|
+714K
|
$0.70
|
+$500.00K
|
|
SEC
|
Wang Theodore T
|
N/A
|
|
+450K
|
$0.70
|
+$315.00K
|
|
SEC
|
Koh Bong Y
|
N/A
|
|
+143K
|
$0.70
|
+$100.00K
|
|
SEC
|
VHCP Management III, LLC
|
N/A
|
|
+143K
|
$0.70
|
+$100.00K
|
|
SEC
|
Koh Bong Y
|
N/A
|
|
+210K
|
$1.20
|
+$252.00K
|
|
SEC
|
Shah Nimish P
|
N/A
|
|
+210K
|
$1.20
|
+$252.00K
|
|
SEC
|
Koh Bong Y
|
N/A
|
|
+475K
|
$1.18
|
+$560.50K
|
|
SEC
|
Shah Nimish P
|
N/A
|
|
+475K
|
$1.18
|
+$560.50K
|
|
SEC
|
Koh Bong Y
|
N/A
|
|
+160K
|
$0.86
|
+$137.60K
|
|
SEC
|
Shah Nimish P
|
N/A
|
|
+160K
|
$0.86
|
+$137.60K
|
|
SEC
|
Koh Bong Y
|
N/A
|
|
+529K
|
$0.65
|
+$344.09K
|
|
SEC
|
Shah Nimish P
|
N/A
|
|
+529K
|
$0.65
|
+$344.09K
|
|
SEC
|
Dekker Martin
|
VP of Engineering & Manuf
|
|
-7.5K
|
$2.37
|
-$17.71K
|
|
SEC
|
Edmonds Amy
|
VP Clinical Operations & Admin
|
|
-7.5K
|
$2.37
|
-$17.77K
|
|
SEC
|
Fernandes Peter
|
Chief Regulatory & Safety Offr
|
|
-11K
|
$2.37
|
-$26.79K
|
|
SEC
|
Quinn Deborah
|
Chief Medical Officer
|
|
-11K
|
$2.37
|
-$24.98K
|
|
SEC
|
Shah Parag Suresh
|
VP Proj Mgmt & Distribution
|
|
-7.1K
|
$2.37
|
-$16.93K
|
|
SEC
|
Tenenbaum Fabian
|
Chief Executive Officer
|
|
-63K
|
$2.37
|
-$150.46K
|
|
SEC
|
Dekker Martin
|
VP of Engineering & Manuf
|
|
-24K
|
$2.49
|
-$60.47K
|
|
SEC
|
Fernandes Peter
|
Chief Regulatory & Safety Offr
|
|
-35K
|
$2.49
|
-$87.95K
|
|
SEC
|
Quinn Deborah
|
Chief Medical Officer
|
|
-33K
|
$2.49
|
-$82.45K
|
|
SEC
|
Shah Parag Suresh
|
VP Proj Mgmt & Distribution
|
|
-23K
|
$2.49
|
-$57.72K
|
|
SEC
|
Schoeps Megan
|
Principal Financial Officer
|
|
+1K
|
$0.49
|
+$490.00
|
|
SEC
|
Schoeps Megan
|
Principal Financial Officer
|
|
-10K
|
$1.40
|
-$14.64K
|
|
SEC
|
Luehring Jens
|
N/A
|
|
+20K
|
$0.56
|
+$11.20K
|
|
SEC
|
Peacock Jonathan M
|
President and CEO
|
|
+5K
|
$1.37
|
+$6.85K
|
|
SEC
|
Peacock Jonathan M
|
President and CEO
|
|
+20K
|
$2.75
|
+$55.83K
|
|
SEC
|
Peacock Jonathan M
|
President and CEO
|
|
+5K
|
$5.48
|
+$27.40K
|
|
SEC
|
MEGLASSON MARTIN
|
Chief Scientific Officer
|
|
+712
|
$8.40
|
+$5.98K
|
|
SEC
|
Peacock Jonathan M
|
President and CEO
|
|
+5.6K
|
$8.69
|
+$48.32K
|
|
SEC
|
BYBEE CLINTON
|
N/A
|
|
+213K
|
$12.00
|
+$2.55M
|
|
SEC
|
Heyrman Reinilde
|
Chief Clinical Dev. Officer
|
|
+1.5K
|
$12.00
|
+$18.00K
|
|
SEC
|
Holt Matthew S.
|
N/A
|
|
+1.1M
|
$12.00
|
+$12.84M
|
|
SEC
|
KLINSKY STEVEN B
|
N/A
|
|
+1.1M
|
$12.00
|
+$12.84M
|
|
SEC
|
Linde North America, Inc.
|
N/A
|
|
+359K
|
$12.00
|
+$4.31M
|
|
SEC
|
Luehring Jens
|
N/A
|
|
+359K
|
$12.00
|
+$4.31M
|
|
SEC
|
MEGLASSON MARTIN
|
Chief Scientific Officer
|
|
+12K
|
$12.00
|
+$144.00K
|
|
SEC
|
Naidu Manesh
|
Chief Business Officer
|
|
+1.5K
|
$12.00
|
+$18.00K
|
|
SEC
|
NELSEN ROBERT
|
N/A
|
|
+213K
|
$12.00
|
+$2.55M
|
|
SEC
|
Peacock Jonathan M
|
President and CEO
|
|
+21K
|
$12.00
|
+$249.60K
|
|
SEC
|
Tasse Daniel
|
N/A
|
|
+25K
|
$12.00
|
+$300.00K
|
|
SEC
|
Weinstein Adam
|
N/A
|
|
+1.1M
|
$12.00
|
+$12.84M
|
|